Reports

This 17th edition of Untangling the Web of Antiretroviral Price Reductions is a departure from recent previous years. For this edition, the methods of collecting information on the sources and prices...

With nearly 13 million people on antiretroviral therapy world-wide, which is less than half the number of people eligible to receive it, the price of antiretroviral (ARV) drugs to put people on treatment...

Opportunities to Revolutionise Care in Developing Countries
This report provides an overview on the current state of play and a framework for action with regards to hepatitis C diagnostics and treatment...

While significant gains made in the fight against HIV/AIDS in the past decade are encouraging, countries most affected by the pandemic continue to struggle to place enough people on treatment and to...

Migrant populations are especially vulnerable to HIV and TB. They are at higher risk of infection, face challenges in accessing care, and have a higher risk of poor adherence, treatment interruption,...

Today, eight million people in developing countries have access to HIV therapy and while many more need to be reached with life-saving medicines, this is important progress. However, the monitoring that...